The 2012 India Chapter traversed the complex challenge of reorganization. It highlighted new models, operating structures, questions around centralization/decentralization, and how clients are driving business in emerging markets. 'Reorganizing for the Future' was a key challenge for the pharma industry given the new set of challenges that they were facing with regard to shrinking pipelines, increased regulatory requirements, shrinking budgets, driving robust growth of emerging world economies, and decreased growth from developed markets.

The event was held on October 19, 2012, at the Four Seasons Hotel, Mumbai.

Reorganizing for the Future

This year, PHARMAFUTURE ™  highlighted the changes that pharma companies are undergoing to meet the shift in the business environment. Market trends forced the companies to rethink their operations strategy, and to implement innovative models to deliver better outcomes, grow brands, reduce costs, and drive innovation.

Event Highlights

  • Thought leadership from senior industry leaders on restructuring of the organization to increase efficiency
  • Understanding shared services models
  • Strategic decisions around reorganization and lessons from global leaders
15:00-16:00 Registration
16:00-16:15 Welcome Note - Gaurav Kapoor, EVP Asia Pac and Emerging Markets, Indegene
16:15-17:00 Keynote: 'Growing for the Future' Mark Mallon, Regional VP - Asia Pacific & President - China, AstraZeneca
17:00-17:30 'Adapting to changing dynamics of the Pharma Environment' - Srini Srinivasan, Global Head, Commercial Strategy & Operations, Novartis Pharma AG
17:30-18:00 Coffee Break
18:00-19:00 Panel Discussion: 'How Regional and Country leaders are Reorganizing for the Future' moderated by Bob Glaser
19:00-19:15 Closing Remarks - Manish Gupta, CEO, Indegene
19:15 Onwards Dinner and Networking

Mark Mallon Regional Vice President
Asia Pacific, AstraZeneca

Mark Mallon is the Regional Vice President for Asia Pacific, where he is accountable for the growth and performance of the AstraZeneca business in 14 markets. His responsibilities include regional strategy development, planning and delivery, while aligning to the Global Commercial Strategy.

Mark was appointed as the President of AstraZeneca China from May 1, 2011, and was responsible for the company’s overall business operations in China and Hong Kong.

Srini Srinivasan Global Head, Commercial Strategy & Operations, Novartis Pharma AG

Srini Srinivasan has over 25 years of experience in various roles including Global Brand Director, Country General Manager, and Area Head for Asia Pacific.

In his current role, he leads Global Commercial Strategy for Primary and Specialty Care, and is also responsible for Global Commercial Organization in Hyderabad.

Prior to Novartis, Srini has extensive experience in branded pharmaceuticals, generics, and vaccines businesses around the globe for GSK & AZ.

Bob Glaser Chief Marketing & Sales Officer, Indegene (Moderator).

Sudarshan Jain Managing Director, Abbott India Ltd.

Ashish D. Pal General Manager, MSD Sun Joint Venture

Sharad Tyagi Managing Director, Boehringer Ingelheim

Anil Matai Chief Executive Officer, Novartis India Ltd